USPTO serial 97142627
MINDTRACE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Aug 18, 2026
- Examiner
- KUNG, KAELIE ELIZABETH
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with MINDTRACE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Pittsburgh, PA, US
Pittsburgh, PA, US
Pittsburgh, PA, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Michael E. Dukes
Michael E. Dukes DENTONS COHEN & GRIGSBY P.C.625 LIBERTY AVENUEPITTSBURGH, PA 15222United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Design and development of medical technologies, namely, imaging apparatuses and equipment all for scientific and medical research; design and development of software in the framework of medical technology; design and development of medical imaging and diagnostic apparatus and developments of medical and scientific procedures and methods for measuring brain structure and function; provision of information in connection with medical and scientific research in the field of neuroscience, neurotechnology, and connectomics; computer programming in the medical field; medical research; biological and medical research services; scientific research in relation to medical technologies, medical apparatus, neuroscience, neurotechnology, cognitive science, healthcare, artificial intelligence and machine learning for the analysis of medical images and other measures of brain structure and function and connectomics; scientific research for medical purposes; scientific research services, namely, scientific research, analysis, and testing in the field of medical imaging and diagnostics and other methods for measuring brain structure and function; scientific and technological services, namely, scientific research, analysis, and testing in the field of medical imaging and diagnostics and other methods for measuring brain structure and function; design and writing of computer software, namely, computer program for medical applications; technical research in the field of neuroscience, cognitive science, machine learning, neurotechnologies and connectomics; design of computers for others; design and development of computer hardware and software for use in neurotechnologies and brain computer interfaces; software design relating to medical technologies, medical apparatus, medical imaging, diagnostic apparatus, neuroscience, neurotechnology, cognitive science, artificial intelligence and machine learning for the analysis of medical images and other measures of brain structure and function and connectomics; software development relating to medical technologies, medical apparatus, medical imaging, diagnostic apparatus, neuroscience, neurotechnology, cognitive science, machine learning and connectomics; research and development of new products in the fields of medical technologies, medical apparatus, medical imaging, diagnostic apparatus, neuroscience, neurotechnology, cognitive science, machine learning and connectomics for others; conducting scientific feasibility studies in the field of neurotechnologies and brain computer interfaces; software development and design; software installation of software relating to medical technologies, medical apparatus, medical imaging, diagnostic apparatus, neuroscience, neurotechnology, cognitive science, machine learning and connectomics; software maintenance of software relating to medical technologies, medical apparatus, medical imaging, diagnostic apparatus, neuroscience, neurotechnology, cognitive science, machine learning and connectomics; updating of software relating to medical technologies, medical apparatus, medical imaging, diagnostic apparatus, neuroscience, neurotechnology, cognitive science, machine learning and connectomics; rental of computer software relating to medical technologies, medical apparatus, medical imaging, diagnostic apparatus, neuroscience, neurotechnology, cognitive science, machine learning and connectomics; computer programming relating to medical technologies, medical apparatus, medical imaging, diagnostic apparatus, neuroscience, neurotechnology, cognitive science, machine learning and connectomics; computer system analysis relating to medical technologies, medical apparatus, medical imaging, diagnostic apparatus, neuroscience, neurotechnology, cognitive science, machine learning and connectomics; computer system design relating to medical technologies, medical apparatus, medical imaging, diagnostic apparatus, neuroscience, neurotechnology, cognitive science, machine learning and connectomics; services provided by consultants relating to computer hardware design and development of computer hardware relating to medical technologies, medical apparatus, medical imaging, diagnostic apparatus, neuroscience, neurotechnology, cognitive science, machine learning and connectomics; cloud computing, namely, cloud hosting provider services for brain imaging data and other measures of brain structure and function; styling being industrial design relating to medical technologies, medical apparatus, medical imaging, diagnostic apparatus, neuroscience, neurotechnology, cognitive science, machine learning and connectomics; software as a service (saas) services featuring software for neuroscience, neurotechnology, and connectomics research for use in the fields of medical and healthcare; software as a service (saas) services featuring software for medical imaging and diagnostics for use in the fields of medical and healthcare; software as a service (saas) services featuring software for diagnosis, treatment, treatment efficacy evaluation, and patient follow-up; software as a service (saas) services featuring software using artificial intelligence and machine learning algorithms to analyze medical images and other measures of brain structure and function; software as a service (saas) services featuring software for use in analyzing, accessing, monitoring, and sharing medical images and other measures of brain structure and function | ACTIVE | Jul 15, 2026 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by MindTrace Technologies, Inc.
- Other trademarks owned by MindTrace Technologies, Inc.
- Other trademarks owned by MindTrace Technologies, Inc.
- Other trademarks in Class 042
- Similar marks named MINDTRACE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 18, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Aug 18, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 27, 2026 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Jul 27, 2026 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Jul 19, 2026 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Jul 17, 2026 | IUAF | USE AMENDMENT FILED | — |
| Jul 17, 2026 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Jun 12, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jun 11, 2026 | EX5G | SOU EXTENSION 5 GRANTED | — |
| Jun 10, 2026 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Jan 20, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jan 19, 2026 | EXT5 | SOU EXTENSION 5 FILED | — |
| Jul 18, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jul 17, 2025 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Jul 17, 2025 | EXT4 | SOU EXTENSION 4 FILED | — |
| Jul 17, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Mar 4, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jan 18, 2025 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Jan 17, 2025 | EXT3 | SOU EXTENSION 3 FILED | — |
| Jan 17, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jul 16, 2024 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jul 16, 2024 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Jul 16, 2024 | EXT2 | SOU EXTENSION 2 FILED | — |
| Jul 16, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jan 20, 2024 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jan 18, 2024 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Jan 18, 2024 | EXT1 | SOU EXTENSION 1 FILED | — |
| Jan 18, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jul 18, 2023 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| May 23, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 23, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 3, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 14, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 14, 2023 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Apr 14, 2023 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Apr 14, 2023 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Apr 14, 2023 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Mar 15, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 14, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 14, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 14, 2022 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 14, 2022 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 14, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 6, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 30, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 27, 2021 | NWAP | NEW APPLICATION ENTERED | — |